Designing autism-friendly trials: Q&A with Caroline Averius and Zachary Williams
The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.
From funding decisions to scientific fraud, a wide range of societal factors shape autism research.
The pair’s new guidebook offers practical steps to make clinical trials easier and more meaningful for autistic participants.
Iama Therapeutics is hoping a new class of molecule will prove successful against an old target in autism.
Two groups are working to increase representation among neuropsychology researchers, in part to improve behavioral assessments for autism.
Their plans stand to improve how autistic children from racial or ethnic minorities are evaluated.
Highlights this week include two gene studies — one on the role of autism-linked genes in developing interneurons and another on the genetic origins of overlapping autism and attention-deficit/hyperactivity disorder.
Here is a roundup of news and research for the week of 26 September.
The talk of the Twittersphere turned around two influential neuroscience papers, plus a virtual trip to the World Congress of Psychiatric Genetics.
Here is a roundup of news and research for the week of 19 September.
Too often, people outside the margins of what’s considered classic autism are left out of research agendas, Abubakare says.
Intentional interactions with autistic people led Sasson to refocus his research.